EGM
LAB icon

Engineers Gate Manager’s Standard BioTools LAB Stock Holding History

Engineers Gate Manager’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,383
Closed -$123K – 2105
2024
Q1 		$123K Buy
45,383
+31,016
+216% +$74.9K ﹤0.01% 1718
2023
Q4 		$31.8K Sell
14,367
-1,971
-12% -$4.21K ﹤0.01% 1880
2023
Q3 		$47.4K Sell
16,338
-1,154
-7% -$3.02K ﹤0.01% 1658
2023
Q2 		$33.8K Buy
17,492
+3,202
+22% +$6.32K ﹤0.01% 1645
2023
Q1 		$27.9K Buy
14,290
+43
+0.3% +$85 ﹤0.01% 1578
2022
Q4 		$16.7K Sell
14,247
-3,103
-18% -$3.82K ﹤0.01% 1609
2022
Q3 		$19K Sell
17,350
-44,909
-72% -$67.9K ﹤0.01% 1538
2022
Q2 		$100K Buy
+62,259
New +$154K ﹤0.01% 1734
2021
Q3 		– Sell
-30,208
Closed -$186K – 1811
2021
Q2 		$186K Sell
30,208
-81,992
-73% -$438K 0.01% 1422
2021
Q1 		$507K Buy
112,200
+100,900
+893% +$554K 0.03% 986
2020
Q4 		$68K Sell
11,300
-2,300
-17% -$15.1K ﹤0.01% 1618
2020
Q3 		$101K Buy
+13,600
New +$93.9K ﹤0.01% 1556
2020
Q2 		– Sell
-41,970
Closed -$107K – 1851
2020
Q1 		$107K Sell
41,970
-152,823
-78% -$502K 0.01% 1403
2019
Q4 		$678K Buy
194,793
+19,526
+11% +$68.7K 0.03% 832
2019
Q3 		$811K Buy
175,267
+40,962
+30% +$323K 0.04% 601
2019
Q2 		$1.66M Buy
134,305
+23,132
+21% +$295K 0.09% 367
2019
Q1 		$1.48M Buy
111,173
+56,704
+104% +$598K 0.09% 334
2018
Q4 		$470K Buy
54,469
+23,761
+77% +$185K 0.04% 542
2018
Q3 		$230K Buy
30,708
+4,518
+17% +$32.1K 0.02% 704
2018
Q2 		$156K Buy
26,190
+4,340
+20% +$24.7K 0.01% 895
2018
Q1 		$128K Buy
+21,850
New +$143K 0.01% 756
2016
Q3 		– Sell
-17,877
Closed -$161K – 685
2016
Q2 		$161K Sell
17,877
-16,505
-48% -$155K 0.01% 635
2016
Q1 		$277K Buy
+34,382
New +$248K 0.02% 578

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Engineers Gate Manager's LAB Position: Q2 2024 in Review

Engineers Gate Manager sold out of Standard BioTools (LAB) in Q2 2024, closing a stake of 45,383 shares — an estimated $123K sold.

Engineers Gate Manager first reported a position in LAB in Q1 2016 and held it in 23 quarters. The position peaked at $1.66M in Q2 2019. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2024.

  • Engineers Gate Manager reported no remaining Standard BioTools position as of Q2 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 45,383 Standard BioTools shares in Q2 2024, an estimated $123K.
  • Engineers Gate Manager first reported a position in Standard BioTools in Q1 2016 and held it in 23 quarters.
  • Engineers Gate Manager's Standard BioTools position peaked at $1.66M in Q2 2019.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2024.

Based on Engineers Gate Manager's 13F filing for Q2 2024, filed 14 Aug 2024.